Nephrology / Original Article
Impaired aldosterone response to potassium and hyperkalemia in patients receiving a renin-angiotensin-aldosterone system inhibitor
Miyeon Kim, Hwa Young Lee, Hyunwoo Kim
Korean J Intern Med. 2025;40(3):468-481. Published online April 30, 2025
Background/Aims: Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) are associated with the development of hyperkalemia. We evaluated the relationship between the serum aldosterone-to-potassium ratio (APR) and the risk of developing hyperkalemia in patients ..
|